The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence

IF 50 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Viknesh Sounderajah, Ahmad Guni, Xiaoxuan Liu, Gary S. Collins, Alan Karthikesalingam, Sheraz R. Markar, Robert M. Golub, Alastair K. Denniston, Shravya Shetty, David Moher, Patrick M. Bossuyt, Ara Darzi, Hutan Ashrafian
{"title":"The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence","authors":"Viknesh Sounderajah, Ahmad Guni, Xiaoxuan Liu, Gary S. Collins, Alan Karthikesalingam, Sheraz R. Markar, Robert M. Golub, Alastair K. Denniston, Shravya Shetty, David Moher, Patrick M. Bossuyt, Ara Darzi, Hutan Ashrafian","doi":"10.1038/s41591-025-03953-8","DOIUrl":null,"url":null,"abstract":"<p>The Standards for Reporting Diagnostic Accuracy (STARD) 2015 statement facilitates transparent and complete reporting of diagnostic test accuracy studies. However, there are unique considerations associated with artificial intelligence (AI)-centered diagnostic test studies. The STARD-AI statement, which was developed through a multistage, multistakeholder process, provides a minimum set of criteria that allows for comprehensive reporting of AI-centered diagnostic test accuracy studies. The process involved a literature review, a scoping survey of international experts, and a patient and public involvement and engagement initiative, culminating in a modified Delphi consensus process involving over 240 international stakeholders and a consensus meeting. The checklist was subsequently finalized by the Steering Committee and includes 18 new or modified items in addition to the STARD 2015 checklist items. Authors are encouraged to provide descriptions of dataset practices, the AI index test and how it was evaluated, as well as considerations of algorithmic bias and fairness. The STARD-AI statement supports comprehensive and transparent reporting in all AI-centered diagnostic accuracy studies, and it can help key stakeholders to evaluate the biases, applicability and generalizability of study findings.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"78 1","pages":""},"PeriodicalIF":50.0000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-025-03953-8","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The Standards for Reporting Diagnostic Accuracy (STARD) 2015 statement facilitates transparent and complete reporting of diagnostic test accuracy studies. However, there are unique considerations associated with artificial intelligence (AI)-centered diagnostic test studies. The STARD-AI statement, which was developed through a multistage, multistakeholder process, provides a minimum set of criteria that allows for comprehensive reporting of AI-centered diagnostic test accuracy studies. The process involved a literature review, a scoping survey of international experts, and a patient and public involvement and engagement initiative, culminating in a modified Delphi consensus process involving over 240 international stakeholders and a consensus meeting. The checklist was subsequently finalized by the Steering Committee and includes 18 new or modified items in addition to the STARD 2015 checklist items. Authors are encouraged to provide descriptions of dataset practices, the AI index test and how it was evaluated, as well as considerations of algorithmic bias and fairness. The STARD-AI statement supports comprehensive and transparent reporting in all AI-centered diagnostic accuracy studies, and it can help key stakeholders to evaluate the biases, applicability and generalizability of study findings.

Abstract Image

使用人工智能进行诊断准确性研究的标准- ai报告指南
报告诊断准确性标准(STARD) 2015声明促进了诊断测试准确性研究的透明和完整报告。然而,以人工智能(AI)为中心的诊断测试研究有一些独特的考虑因素。通过多阶段、多利益相关者流程制定的标准- ai声明提供了一套最低标准,允许全面报告以人工智能为中心的诊断测试准确性研究。该过程包括文献综述、国际专家的范围调查、患者和公众参与和参与倡议,最终形成了涉及240多个国际利益相关者的修改后的德尔菲共识过程和共识会议。该清单随后由指导委员会定稿,除标准2015清单项目外,还包括18个新的或修改的项目。鼓励作者提供数据集实践,人工智能指数测试及其评估方式的描述,以及对算法偏见和公平性的考虑。star - ai声明支持在所有以人工智能为中心的诊断准确性研究中进行全面和透明的报告,它可以帮助关键利益相关者评估研究结果的偏差、适用性和普遍性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nature Medicine
Nature Medicine 医学-生化与分子生物学
CiteScore
100.90
自引率
0.70%
发文量
525
审稿时长
1 months
期刊介绍: Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信